These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9294163)

  • 21. [Directed evolution of antibody molecules in phage-displayed combinatorial libraries].
    Fujii I
    Yakugaku Zasshi; 2007 Jan; 127(1):91-9. PubMed ID: 17202788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity.
    Buchbinder JL; Stephenson RC; Scanlan TS; Fletterick RJ
    J Mol Biol; 1998 Oct; 282(5):1033-41. PubMed ID: 9753552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display.
    McCafferty J; Fitzgerald KJ; Earnshaw J; Chiswell DJ; Link J; Smith R; Kenten J
    Appl Biochem Biotechnol; 1994; 47(2-3):157-71; discussion 171-3. PubMed ID: 7944335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of antibody selection by phage display utilizing anti-phenobarbital antibodies.
    Malone J; Sullivan MA
    J Mol Recognit; 1996; 9(5-6):738-45. PubMed ID: 9174966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of catalytically active biotin ligase and trypsin mutants by phage display.
    Heinis C; Huber A; Demartis S; Bertschinger J; Melkko S; Lozzi L; Neri P; Neri D
    Protein Eng; 2001 Dec; 14(12):1043-52. PubMed ID: 11809935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNF alpha monoclonal antibodies.
    Mahler SM; Marquis CP; Brown G; Roberts A; Hoogenboom HR
    Immunotechnology; 1997 Mar; 3(1):31-43. PubMed ID: 9154466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage versus phagemid libraries for generation of human monoclonal antibodies.
    O'Connell D; Becerril B; Roy-Burman A; Daws M; Marks JD
    J Mol Biol; 2002 Aug; 321(1):49-56. PubMed ID: 12139932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer.
    Wu BP; Xiao B; Wan TM; Zhang YL; Zhang ZS; Zhou DY; Lai ZS; Gao CF
    World J Gastroenterol; 2001 Dec; 7(6):811-5. PubMed ID: 11854907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates].
    Mokrushina YA; Pipiya SO; Stepanova AV; Shamborant OG; Knorre VD; Smirnov IV; Gabibov AG; Vorobiev II
    Mol Biol (Mosk); 2017; 51(6):958-968. PubMed ID: 29271960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of phage-displayed peptides that bind to a particular ligand-bound antibody.
    Tanaka F; Hu Y; Sutton J; Asawapornmongkol L; Fuller R; Olson AJ; Barbas CF; Lerner RA
    Bioorg Med Chem; 2008 Jun; 16(11):5926-31. PubMed ID: 18472269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein and Antibody Engineering by Phage Display.
    Frei JC; Lai JR
    Methods Enzymol; 2016; 580():45-87. PubMed ID: 27586328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleophilic proteolytic antibodies.
    Gololobov G; Tramontano A; Paul S
    Appl Biochem Biotechnol; 2000; 83(1-3):221-31; discussion 231-2, 297-313. PubMed ID: 10826962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological origins of binding and catalysis in a Diels-Alderase antibody.
    Romesberg FE; Spiller B; Schultz PG; Stevens RC
    Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses.
    Chin SE; Ferraro F; Groves M; Liang M; Vaughan TJ; Dobson CL
    J Immunol Methods; 2015 Jan; 416():49-58. PubMed ID: 25449532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzymatic characterization of glycosidase antibodies raised against a chair transition state analog and the retained catalytic activity from the expressed single chain antibody fragments.
    Choi SO; Youn HJ; Yu J
    Mol Cells; 2002 Jun; 13(3):463-9. PubMed ID: 12132587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.